Pía M. Vidal

Dr. Pía M. Vidal

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JOJorge Ojeda
Jorge Ojeda
AAAriel Avila
Ariel Avila
PVPía M. Vidal
Pía M. Vidal
During the last years, accumulating evidence has suggested that the gut microbiota plays a key role in the pathogenesis of neurodevelopmental and neurodegenerative diseases via the gut–brain axis. Moreover, current research has helped to elucidate different communication pathways between the gut microbiota and neural tissues (e.g., the vagus nerve, tryptophan production, extrinsic enteric-associated neurons, and short chain fatty acids). On the other hand, altering the composition of gut microbiota promotes a state known as dysbiosis, where the balance between helpful and pathogenic bacteria is disrupted, usually stimulating the last ones. Herein, we summarize selected findings of the recent literature concerning the gut microbiome on the onset and progression of neurodevelopmental and degenerative disorders, and the strategies to modulate its composition in the search for therapeutical approaches, focusing mainly on animal models studies. Readers are advised that this is a young field, based on early studies, that is rapidly growing and being updated as the field advances.

1 February 2013 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
PVPía M. Vidal
Pía M. Vidal
ELEvi Lemmens
Evi Lemmens
Dearbhaile DooleyDearbhaile Dooley
Dearbhaile Dooley
SHSven Hendrix
Sven Hendrix

2 June 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
PVPía M. Vidal
Pía M. Vidal
SKSpyridon K. Karadimas
Spyridon K. Karadimas
AUAntigona Ulndreaj
Antigona Ulndreaj
ALAlex M. Laliberte
Alex M. Laliberte
LTLindsay Tetreault
Lindsay Tetreault
Michael FehlingsMichael Fehlings
Michael Fehlings
Degenerative cervical myelopathy (DCM) is the most common progressive nontraumatic spinal cord injury. The most common recommended treatment is surgical decompression, although the optimal timing of intervention is an area of ongoing debate. The primary objective of this study was to assess whether a delay in decompression could influence the extent of ischemia-reperfusion injury and alter the trajectory of outcome in DCM. Using a DCM mouse model, we show that decompression acutely led to a 1.5- to 2-fold increase in levels of inflammatory cytokines within the spinal cord. Delayed decompression was associated with exacerbated reperfusion injury, astrogliosis, and poorer neurological recovery. Additionally, delayed decompression was associated with prolonged elevation of inflammatory cytokines and an exacerbated peripheral monocytic inflammatory response ( P < 0.01 and 0.001). In contrast, early decompression led to resolution of reperfusion-mediated inflammation, neurological improvement, and reduced hyperalgesia. Similar findings were observed in subjects from the CSM AOSpine North America and International studies, where delayed decompressive surgery resulted in poorer neurological improvement compared with patients with an earlier intervention. Our data demonstrate that delayed surgical decompression for DCM exacerbates reperfusion injury and is associated with ongoing enhanced levels of cytokine expression, microglia activation, and astrogliosis, and paralleled with poorer neurological recovery.

1 August 2013 in Cell Reports
Verified
Journal Article
Open access
AAAriel Avila
Ariel Avila
PVPía M. Vidal
Pía M. Vidal
TDT. Neil Dear
T. Neil Dear
Robert HarveyRobert Harvey
Robert Harvey
JRJean-Michel Rigo
Jean-Michel Rigo
LNLaurent Nguyen
Laurent Nguyen
Glycine receptors (GlyRs) are detected in the developing CNS before synaptogenesis, but their function remains elusive. This study demonstrates that functional GlyRs are expressed by embryonic cortical interneurons in vivo. Furthermore, genetic disruption of these receptors leads to interneuron migration defects. We discovered that extrasynaptic activation of GlyRs containing the α2 subunit in cortical interneurons by endogenous glycine activates voltage-gated calcium channels and promotes calcium influx, which further modulates actomyosin contractility to fine-tune nuclear translocation during migration. Taken together, our data highlight the molecular events triggered by GlyR α2 activation that control cortical tangential migration during embryogenesis.


19 January 2019 in Journal of Neuroimmune Pharmacology
Verified
Journal Article
Closed access
PDF file
PVPía M. Vidal
Pía M. Vidal
Rodrigo PachecoRodrigo Pacheco
Rodrigo Pacheco